Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| FiEE, Inc. | 2,681,980 | reported | 18 Feb 2025 | tx 8+7,787,337−5,019,447 |
| Sow Good Inc. | 1,500,000 | reported | 31 Dec 2025 | tx 1+1,500,000 |
| MAINZ BIOMED N.V. | 1,000,000 | reported | 22 Apr 2026 | tx 5+5,000,000 |
| XCYTE THERAPIES INC | 155,838 | reported | 30 Jul 2025 | tx 7+196,728,820−197,380,832 |
| Indaptus Therapeutics, Inc. | 103,200 | reported | 23 Mar 2026 | tx 2−896,800 |
| LQR House Inc. | 100,000 | reported | 02 Apr 2025 | tx 3+100,000−1,101,818 |
| TITAN PHARMACEUTICALS INC | 100,000 | reported | 26 Jul 2023 | tx 4+2,326,190 |
| KALA BIO, Inc. | 0 | reported | 18 Dec 2025 | tx 2+900,000−368,614 |
| NovaBay Pharmaceuticals, Inc. | 0 | reported | 21 Oct 2025 | tx 3+6,388,000−481,250 |
| OPGEN INC | 0 | reported | 30 Jul 2024 | tx 6+800,000−550,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 Apr 2026 | GRANT_AWARD | MAINZ BIOMED N.V. | 1,000,000 | 1.50 USD | deriv |
| 22 Apr 2026 | GRANT_AWARD | MAINZ BIOMED N.V. | 1,000,000 | 1.50 USD | deriv |
| 23 Mar 2026 | SALE | Indaptus Therapeutics, Inc. | 196,800 | — | deriv |
| 23 Mar 2026 | SALE | Indaptus Therapeutics, Inc. | 700,000 | — | deriv |
| 13 Feb 2026 | GRANT_AWARD | MAINZ BIOMED N.V. | 1,000,000 | — | deriv |
| 13 Feb 2026 | GRANT_AWARD | MAINZ BIOMED N.V. | 1,000,000 | — | deriv |
| 13 Feb 2026 | GRANT_AWARD | MAINZ BIOMED N.V. | 1,000,000 | — | deriv |
| 21 Oct 2025 | GRANT_AWARD | NovaBay Pharmaceuticals, Inc. | 6,388,000 | — | |
| 21 Oct 2025 | EXERCISE | NovaBay Pharmaceuticals, Inc. | 39,925 | — | deriv |
| 31 Dec 2025 | GRANT_AWARD | Sow Good Inc. | 1,500,000 | 2.00 USD | deriv |
| 18 Dec 2025 | OTHER | KALA BIO, Inc. | 368,614 | — | deriv |
| 24 Nov 2025 | GRANT_AWARD | KALA BIO, Inc. | 900,000 | — | deriv |
| 16 Oct 2025 | SALE | NovaBay Pharmaceuticals, Inc. | 441,325 | — | deriv |
| 30 Jul 2025 | SALE | XCYTE THERAPIES INC | 6,750 | 12.36 USD | |
| 02 Apr 2025 | GRANT_AWARD | LQR House Inc. | 100,000 | 0.00 USD | |
| 18 Feb 2025 | GRANT_AWARD | FiEE, Inc. | 1,200,000 | — | |
| 18 Feb 2025 | SALE | FiEE, Inc. | 2,219,447 | — | deriv |
| 18 Feb 2025 | SALE | FiEE, Inc. | 2,800,000 | — | deriv |
| 26 Feb 2025 | SALE | XCYTE THERAPIES INC | 194,628,820 | 0.03 USD | |
| 26 Feb 2025 | EXERCISE | XCYTE THERAPIES INC | 2,650,000 | — | |
| 26 Feb 2025 | EXERCISE | XCYTE THERAPIES INC | 191,978,820 | — | |
| 26 Feb 2025 | EXERCISE | XCYTE THERAPIES INC | 1,000,000 | — | deriv |
| 26 Feb 2025 | EXERCISE | XCYTE THERAPIES INC | 1,745,262 | — | deriv |
| 06 Feb 2025 | GRANT_AWARD | XCYTE THERAPIES INC | 2,100,000 | — | deriv |
| 26 Dec 2024 | PURCHASE | FiEE, Inc. | 1,456,980 | 0.03 USD |
1 purchase reported after at least 12 months of silence — most recent on 29 Jan 2024.